$ASAN

Megji Aziz sold $211K of ASAN

Megji Aziz (Chief Financial Officer) sold 31,696 shares of Asana, Inc. (ASAN) at an average of $6.66 ($6.65–$6.66, $0.21M total) across 2 trades on 2026-06-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Megji Aziz
Published Jun 24, 2026, 10:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 24, 2026, 10:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ASAN
Neutral
high confidence
Mentioned
$ASAN
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ASANNeutralLow
01

Why it matters

The newest disclosed fact is the executed open-market sale of 31,696 shares at an average ~$6.6567 under a pre-arranged 10b5-1 plan; this is generally treated as lower-signal than discretionary selling.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 designation and modest dollar value suggest limited fundamental read-through.

03

What to watch

The sale size (~$211K) is modest relative to typical institutional flows; without accompanying guidance, product, or financial updates, the market impact should be limited.

Relevance 3/10Novelty 3/10Timing: Form 4 filed 2026-06-24; sale executed 2026-06-22

Background

The article is an SEC Form 4 insider transaction disclosure for Asana, Inc. (ASAN) by CFO Megji Aziz.

Company-level read

Ticker impact

$ASANNeutralHigh confidence
Context

Asana CFO Megji Aziz sold ~$211K of ASAN shares via a 10b5-1 plan, disclosing 31,696 shares at ~$6.65 on 2026-06-22.

Expected impact

Low likelihood of a sustained price move solely from this Form 4 sale; any reaction would be short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction with explicit 10b5-1 pre-arrangement, reducing interpretive weight versus discretionary selling.

Market effects

Minimal; this is company-specific insider activity, not a sector-wide catalyst.

None.

None.

Counterpoint

Even with 10b5-1, repeated insider sales can coincide with executives de-risking ahead of known personal liquidity needs, which some traders may still front-run.

Key entities

  • Asana, Inc.

    Subject of the Form 4 insider transaction; CFO Megji Aziz sold shares under a 10b5-1 plan.

  • Megji Aziz

    Asana CFO; reported open-market sale of 31,696 shares on 2026-06-22.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ASANMed

Asana (ASAN) Q2 2027 Earnings Call Transcript

Asana (ASAN) reported Q2 2027 revenue of $216.4M, up 10% YoY, exceeding guidance. Non-GAAP operating margin was 10.1%, up 300 bps YoY. Net retention rates improved across all cohorts, with AI products driving 25% of net new ARR. The company faces PLG headwinds and gross margin pressure due to AI investments. Q3 revenue guidance is $217M-$219M, with full-year revenue expected at $858.5M-$863.5M, up 9% at the midpoint.

$NVDAHighAI 8/10

Consumer Tech (Aug 31-Sep 4): NVIDIA Buys World's Largest Open AI Developer, Trump Claims Total Control On Hormuz & More

NVIDIA (NVDA) agreed to acquire Hugging Face for $12.93B. Ambarella (AMBA), Asana (ASAN), Samsara (IOT), and others reported earnings beats. Dell (DELL) and Salesforce (CRM) saw strong AI-driven demand. NIO (NIO) missed revenue estimates. TSMC (TSM) raised chip equipment spending. Meta (META) opposed AI regulation. Broadcom (AVGO) and Microsoft (MSFT) expanded AI chip and reporting initiatives.

$ASANMedAI 8/10

Asana, Inc. Q2 2027 Earnings Call Summary

Asana (ASAN) reported Q2 2027 revenue beat, driven by U.S. growth and AI products contributing 25% of net new ARR. Management raised AI product target to 20% of net new ARR for the year. Gross margins expected to exit in mid-80s due to AI costs. Guidance includes a $1.2M revenue timing headwind from consumption-based billing. New applications expected to contribute meaningfully in 2028.

$ASANHighAI 8/10

Asana Shares Fall 10.9% as Q3 Outlook Follows Q2 Earnings Beat

Asana (ASAN) shares dropped 10.9% in pre-market trading after reporting Q2 revenue of $216.4M, up 10% YoY, and adjusted EPS of $0.10, beating estimates. Q3 guidance was below expectations, with revenue forecasted at $217M-$219M and adjusted EPS at $0.08. Gross margin declined to 87% due to AI costs and integration expenses. Analysts maintained ratings but adjusted price targets.

$ASANMedAI 8/10

Asana (ASAN) Reached a 10% Non-GAAP Operating Margin. Can Agentic Products Restore Expansion?

Asana (ASAN) reported Q2 2027 revenue of $216.4M, up 10% YoY, with a 10.1% non-GAAP operating margin. Core revenue grew 11%, and cash flow improved. Agentic Work Management, launching Q3, may introduce new revenue streams. Retention remains a concern at 97%. GAAP vs. non-GAAP margin gap is significant. Fiscal 2027 guidance expects ~9% revenue growth and ~10% non-GAAP margin.

$ASANMedAI 8/10

Why Asana Stock Flailed on Friday

Asana (ASAN) reported Q2 2027 earnings, beating revenue and profit estimates with 10% revenue growth to $216.4M. Core clients and high-spending customers increased by 7% and 16%, respectively. Adjusted net income rose 57% to $23.8M. Despite positive results, shares fell 13% on Friday due to guidance showing slightly lower growth expectations of around 9% for the full year, below investor hopes for stronger growth.